Innate Repair
Team and Advisors
Ronen Leker
Professor Ronen R. Leker MD, FAHA is the Director of the Stroke Unit, Stroke Center and the Peritz and Chantal Sheinberg Cerebrovascular Research Laboratory and Jacob L. Sebulsky Chair in Neurology, Department of Neurology, at the Hadassah-Hebrew University Medical Center
Deric M. Park
Deric M. Park, MD, FACP is Associate Professor of Neurology at the University of Chicago, Director of Medical Neuro-Oncology, and a faculty member of the Committee on Clinical Pharmacology and Pharmacogenomics. He is committed to identifying more effective therapies for patients suffering from brain-spine tumors.
Steven W. Poser
Steven received his Ph.D. from the University of Washington in Neurobiology. In both industry and academic laboratories, he successfully designed and implemented signal transduction and cell characterization studies in cancer, stem cell, and primary neuronal culture systems. These became an integral part of cell-based product development and drug discovery programs as well as resulted in numerous publications.
Andreas Androutsellis-Theotokis
Andreas is the chief scientist and inventor at Innate Repair. He studied at Imperial College, London (BSc, PhD) and performed research at Yale and the NIH. He has run his own labs at the TU Dresden (Group Leader) and the University of Nottingham (Assoc. Prof.).
TU Dresden
The TU Dresden is a public research university. It ranks among the best universities of engineering and technology in Germany. It is a member of TU9, a consortium of the nine leading German Institutes of Technology and one of eleven German universities with the title "University of Excellence".
Stefan R. Bornstein
Stefan is the Director of the Centre for Internal Medicine and the Medical Clinic and Policlinic III at the University Hospital Carl Gustav Carus of the Technical University of Dresden as well as the medical faculty’s Vice Dean of International Affairs and Development and a member of the supervisory board of the University Hospital of Dresden. Furthermore, he is Chair and Honorary Consultant for Diabetes and Endocrinology at King's College London.
Andrew V. Schally
Andrew is an Endocrine Oncologist and Distinguished Medical Research Scientist of the US Veteran Affairs Department, as well as Professor of Pathology, Professor of Medicine, Division of Oncology, and Endocrinology at the University of Miami. He is a recipient of the Nobel prize in Physiology or Medicine.
Gregor Mueller
Gregor will be responsible for the operation of iRSN. He studied biology in Cologne. As staff scientist of a spin-off from the Heinrich Heine University Düsseldorf he was awarded his PhD in gene therapy. For six years he worked as group leader at the Carl Gustav Carus Faculty of Medicine of the TU Dresden. As a GWT-GmbH senior consultant he has been the head of the Grant Writing Office of the Department of Internal Medicine at the University Hospital Carl Gustav Carus since 2009. In 2020 he became the COO of the transCelerator program, funded by the Excellence Initiative "TUD 2028 - Synergy and beyond" of TU Dresden.
George P. Chrousos
George is Professor of Pediatrics and Endocrinology, Chairman, First Dept. of Pediatrics, National and Kapodistrian University of Athens. He holds a UNESCO Chair, has received numerous international awards and is a member of the US National Academy of Medicine (Institute of Medicine).